Literature DB >> 22302851

Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Anoli J Borad1, Geneve M Allison, David Wang, Sabeena Ahmed, Mohammad M Karim, Anne V Kane, Joy Moy, Patricia L Hibberd, Sitara Swarna Rao Ajjampur, Gagandeep Kang, Stephen B Calderwood, Edward T Ryan, Elena Naumova, Wasif A Khan, Honorine D Ward.   

Abstract

Cryptosporidium is a major cause of diarrhea in children in developing countries. However, there is no vaccine available and little is known about immune responses to protective antigens. We investigated antibody responses to p23, a putative vaccine candidate, in children in Bangladesh with cryptosporidiosis and diarrhea (cases) and uninfected children with diarrhea (controls), and p23 gene polymorphisms in infecting species. Serum IgM, IgG, and IgA responses to p23 were significantly greater in cases than controls after three weeks of follow-up. Cases with acute diarrhea had significantly greater serum IgA and IgM responses than those with persistent diarrhea, which suggested an association with protection from prolonged disease. The p23 sequences were relatively conserved among infecting species and subtype families. Although most children were infected with Cryptosporidium hominis, there was a cross-reactive antibody response to C. parvum antigen. These results support further development of p23 as a vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302851      PMCID: PMC3269270          DOI: 10.4269/ajtmh.2012.11-0273

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  61 in total

1.  Nucleotide changes within three Cryptosporidium parvum surface protein encoding genes differentiate genotype I from genotype II isolates.

Authors:  Gregory D Sturbaum; B Helen Jost; Charles R Sterling
Journal:  Mol Biochem Parasitol       Date:  2003-04-25       Impact factor: 1.759

2.  Screening of the T- and B-cell antigenicity in neonatal calves of the His-tagged Cryptosporidium parvum antigens CP15, CP15/60, P23 and TRAP-C1.

Authors:  Dirk C de Graaf; Hans De Coninck; Cathérine De Clercq; Johan E Peeters
Journal:  Folia Parasitol (Praha)       Date:  2002       Impact factor: 2.122

3.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Detection of mucosally delivered antibody to Cryptosporidium parvum p23 in infected calves.

Authors:  C R Wyatt; L E Perryman
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Evidence for the emergence of a type-1-like immune response in intestinal mucosa of calves recovering from cryptosporidiosis.

Authors:  C R Wyatt; E J Brackett; J Savidge
Journal:  J Parasitol       Date:  2001-02       Impact factor: 1.276

6.  Human T and B cell immunoreactivity to a recombinant 23-kDa Cryptosporidium parvum antigen.

Authors:  L M Smith; J W Priest; P J Lammie; J R Mead
Journal:  J Parasitol       Date:  2001-06       Impact factor: 1.276

7.  Recombinant bovine herpesvirus-1 expressing p23 protein of Cryptosporidium parvum induces neutralizing antibodies in rabbits.

Authors:  Yasuhiro Takashima; Xuenan Xuan; Isao Kimata; Motohiro Iseki; Yoshikatsu Kodama; Noriko Nagane; Hideyuki Nagasawa; Yasunobu Matsumoto; Takeshi Mikami; Haruki Otsuka
Journal:  J Parasitol       Date:  2003-04       Impact factor: 1.276

8.  Cryptosporidium species: new insights and old challenges.

Authors:  Brett A Leav; Melanie Mackay; Honorine D Ward
Journal:  Clin Infect Dis       Date:  2003-03-18       Impact factor: 9.079

Review 9.  Recent advances in cryptosporidiosis: the immune response.

Authors:  Michael W Riggs
Journal:  Microbes Infect       Date:  2002-08       Impact factor: 2.700

Review 10.  Cryptosporidiosis: epidemiology and impact.

Authors:  Rebecca A Dillingham; Aldo A Lima; Richard L Guerrant
Journal:  Microbes Infect       Date:  2002-08       Impact factor: 2.700

View more
  16 in total

1.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

2.  Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.

Authors:  Jane W Wanyiri; Henry Kanyi; Samuel Maina; David E Wang; Aaron Steen; Paul Ngugi; Timothy Kamau; Tabitha Waithera; Roberta O'Connor; Kimani Gachuhi; Claire N Wamae; Mkaya Mwamburi; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

3.  Rapid microfluidic immunoassay for surveillance and diagnosis of Cryptosporidium infection in human immunodeficiency virus-infected patients.

Authors:  Li Zhang; Yongfeng Fu; Wenwen Jing; Qing Xu; Wang Zhao; Meng Feng; Hiroshi Tachibana; Guodong Sui; Xunjia Cheng
Journal:  Biomicrofluidics       Date:  2015-04-14       Impact factor: 2.800

Review 4.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

Review 5.  Burden of disease from cryptosporidiosis.

Authors:  Debbie-Ann T Shirley; Shannon N Moonah; Karen L Kotloff
Journal:  Curr Opin Infect Dis       Date:  2012-10       Impact factor: 4.915

6.  Identification and characterization of a new 34 kDa MORN motif-containing sporozoite surface-exposed protein, Cp-P34, unique to Cryptosporidium.

Authors:  Justyna J Jaskiewicz; Jacqueline M Tremblay; Saul Tzipori; Charles B Shoemaker
Journal:  Int J Parasitol       Date:  2021-03-25       Impact factor: 4.330

Review 7.  Prospects for immunotherapy and vaccines against Cryptosporidium.

Authors:  Jan R Mead
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

8.  Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.

Authors:  John R Haserick; Joshua A Klein; Catherine E Costello; John Samuelson
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

9.  The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS).

Authors:  Samba O Sow; Khitam Muhsen; Dilruba Nasrin; William C Blackwelder; Yukun Wu; Tamer H Farag; Sandra Panchalingam; Dipika Sur; Anita K M Zaidi; Abu S G Faruque; Debasish Saha; Richard Adegbola; Pedro L Alonso; Robert F Breiman; Quique Bassat; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Anowar Hossain; Sumon K Das; Martin Antonio; M Jahangir Hossain; Inacio Mandomando; Tacilta Nhampossa; Sozinho Acácio; Richard Omore; Joseph O Oundo; John B Ochieng; Eric D Mintz; Ciara E O'Reilly; Lynette Y Berkeley; Sofie Livio; Sharon M Tennant; Halvor Sommerfelt; James P Nataro; Tomer Ziv-Baran; Roy M Robins-Browne; Vladimir Mishcherkin; Jixian Zhang; Jie Liu; Eric R Houpt; Karen L Kotloff; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2016-05-24

10.  Serum Anti-Cryptosporidial gp15 Antibodies in Mothers and Children Less than 2 Years of Age in India.

Authors:  Robin P Lazarus; Sitara S R Ajjampur; Rajiv Sarkar; Jayanthy C Geetha; Ashok D Prabakaran; Vasanth Velusamy; Elena N Naumova; Honorine D Ward; Gagandeep Kang
Journal:  Am J Trop Med Hyg       Date:  2015-08-24       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.